Indivior PLC (LON: INDV) Indivior announced on 5/15/18 that its U.S. subsidiary, Indivior Inc., together with Aquestive Therapeutics, Inc. (formerly known as Monosol Rx, LLC), entered into a... read more
Indivior PLC (LON: INDV) Indivior announced on 5/15/18 that its U.S. subsidiary, Indivior Inc., together with Aquestive Therapeutics, Inc. (formerly known as Monosol Rx, LLC), entered into a... read more
UTILITY therapeutics Ltd (“UTILITY” or “the Company”), a pharmaceutical company focused on developing and commercializing antibiotics in the US, announced on 5/15/18 the signature of an exclusive... read more
Celsius Therapeutics, launched on 5/15/18 with a $65 million Series A financing led by Third Rock Ventures with participation from GV (formerly Google Ventures), Heritage Provider Network, Casdin... read more
Intellia Therapeutics, Inc. (NASDAQ:NTLA), announced on 5/14/18 the addition of new scientific advisors in immuno-oncology and autoimmunity. The advisors hail from prestigious international... read more
Beam Therapeutics announced today that it is launching to develop precision genetic medicines that make edits to individual base pairs in the genetic code. Co-founded by scientific pioneers known... read more